Table 2 Factors associated with heart failure among patients on hemodialysis therapy
Characteristic | N | Heart failure | p Value | |
|---|---|---|---|---|
Present | Absent | |||
Age (years) | 160 | 56.1 ± 11.4 | 51.8 ± 13.4 | NS |
% Male | 160 | 70.6 | 69.2 | NS |
% Diabetes mellitus | 160 | 58.8 | 41.3 | NS |
Pre-dialysis MAP (mmHg) | 160 | 105 ± 12 | 107 ± 15 | NS |
Post-dialysis MAP (mmHg) | 160 | 110 ± 10 | 106 ± 14 | NS |
Duration on HD (months) * | 160 | 18 (9.5–39) | 18 (7–28) | NS |
Urea reduction ratio (%) | 160 | 71.8 ± 7.9 | 70.0 ± 11.7 | NS |
Body mass index (kg/m2) | 160 | 21.9 ± 3.7 | 22.5 ± 4.0 | NS |
Serum albumin (g/dl) | 160 | 3.69 ± 0.41 | 3.72 ± 0.49 | NS |
Total cholesterol (mg/dl) | 160 | 138 ± 41 | 154 ± 39 | NS |
C-reactive protein (mg/l) * | 103 | 22.4 (11.2–62) | 15 (6.0–34) | NS |
Malnutrition inflammation score (MIS) * | 160 | 10 (5–12.5) | 5 (4–10) | 0.04 |
Total leucocyte count (× 109/l) | 160 | 4.7 ± 1.8 | 5.1 ± 2.3 | NS |
Hemoglobin (g/dl) | 160 | 8.3 ± 2.2 | 9.4 ± 1.9 | 0.02 |
Serum transferrin (mg/dl) | 160 | 171 ± 32 | 196 ± 51 | NS |
Serum ferritin (ng/ml)* | 102 | 115 (74–243) | 117 (54–275) | NS |
Erythropoietin resistance index, ERI (U/kg per g/dl) | 120 | 25.4 ± 10.8 | 19.3 ± 8.0 | 0.01 |